BBWI241115P22500
- 0.03
- -0.02-40.00%
Bath & Body Works Newsroom
Morgan Stanley Maintains Bath & Body Works(BBWI.US) With Buy Rating, Cuts Target Price to $48
Morgan Stanley Adjusts Price Target on Bath & Body Works to $48 From $51, Maintains Overweight Rating
Barclays Downgrades Bath & Body Works(BBWI.US) to Sell Rating, Cuts Target Price to $28
Bath & Body Works Analyst Ratings
Wells Fargo Maintains Bath & Body Works(BBWI.US) With Hold Rating, Cuts Target Price to $32
BofA Securities Maintains Bath & Body Works(BBWI.US) With Buy Rating, Maintains Target Price $45
J.P. Morgan Maintains Bath & Body Works(BBWI.US) With Hold Rating
Bath & Body Works Analyst Ratings
Baird Maintains Bath & Body Works(BBWI.US) With Buy Rating, Maintains Target Price $45
Telsey Advisory Maintains Bath & Body Works(BBWI.US) With Buy Rating, Cuts Target Price to $42
BMO Capital Maintains Bath & Body Works(BBWI.US) With Buy Rating, Maintains Target Price $50
Buy Rating Affirmed for Bath & Body Works Amid Strategic Management Changes and Solid Financial Outlook
TD Cowen Maintains Bath & Body Works(BBWI.US) With Buy Rating, Maintains Target Price $40
Morgan Stanley Maintains Bath & Body Works(BBWI.US) With Buy Rating, Maintains Target Price $51
Morgan Stanley Maintains Overweight on Bath & Body Works, Lowers Price Target to $51
Morgan Stanley Maintains Bath & Body Works(BBWI.US) With Buy Rating, Cuts Target Price to $51
Crafting a Buy Rating: Insights From Alexandra Straton's Bath & Body Works Analysis
A Quick Look at Today's Ratings for Bath & Body Works(BBWI.US), With a Forecast Between $38 to $56
Bath & Body Works Price Target Cut to $42.00/Share From $53.00 by Telsey Advisory Group
A Quick Look at Today's Ratings for Bath & Body Works(BBWI.US), With a Forecast Between $35 to $56